| Type: | Pharmaceutical Intermediates |
|---|---|
| Other Names: | AB-FUBINACA |
| CAS No.: | 1185282-01-2 |
Quick Details
Specifications
Abchminaca Research Chemical CAS NO.1185282-01-2
Quick Details
ProName: Abchminaca Research ChemicalCasNo: 1185282-01-2Appearance: White or similar crystalline powderApplication: widely used for research and forensic DeliveryTime: in 1-2 days after paymentPackAge: Aluminum foil bag or customized bagPort: shanghai,guangzhou,Hong KongProductionCapacity: 1000 Kilogram/MonthPurity: 99.50%Storage: A cool and dry environmentTransportation: by air or by seaLimitNum: 10 Gram
Superiority
AB-FUBINACA is a drug that acts as a potent agonist for the cannabinoid receptors, with Ki values of 0.9nM at CB1 and 23.2nM at CB2. It was originally developed by Pfizer in 2009 as an analgesic medication,[1] but was never pursued for human use. Subsequently in 2012, this compound was discovered as an ingredient in synthetic cannabis blends in Japan,[2]along with a related compound AB-PINACA which had not previously been reported.
Quick Details
ProName: Abchminaca Research ChemicalCasNo: 1185282-01-2Appearance: White or similar crystalline powderApplication: widely used for research and forensic DeliveryTime: in 1-2 days after paymentPackAge: Aluminum foil bag or customized bagPort: shanghai,guangzhou,Hong KongProductionCapacity: 1000 Kilogram/MonthPurity: 99.50%Storage: A cool and dry environmentTransportation: by air or by seaLimitNum: 10 Gram
Superiority
AB-FUBINACA is a drug that acts as a potent agonist for the cannabinoid receptors, with Ki values of 0.9nM at CB1 and 23.2nM at CB2. It was originally developed by Pfizer in 2009 as an analgesic medication,[1] but was never pursued for human use. Subsequently in 2012, this compound was discovered as an ingredient in synthetic cannabis blends in Japan,[2]along with a related compound AB-PINACA which had not previously been reported.